Search

everythinglearnresearchcommunity

for

Search:↓

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

Targeting CD169+ skin macrophages may help treat psoriasis.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Self-compassion can help reduce body shame and psychological distress in people with alopecia and psoriasis.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Guselkumab significantly improves quality of life for people with moderate to severe psoriasis.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Inflammation in psoriasis may trigger antimicrobial peptides and cell death.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Certain proteins and cytokines are key in causing psoriatic skin issues.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

ILC1-like cells can cause alopecia areata by themselves.

Sandalore®, a synthetic scent, reduced hair loss and improved hair growth in women with telogen effluvium.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Using neurohormones to control keratin can lead to new skin disease treatments.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Adding a specific gene to skin cells can help treat skin disorders like psoriasis.

Poly(ADP-ribose) synthesis is linked to skin cell differentiation.